Company intelligence / Profile preview

WEDERM Global

Hong Kong, Hong Kong

Ownership: Private
Development stage: Other

Overview

WEDERM is a Hong Kong-based biotechnology company specializing in dermatological solutions and medical-grade skincare. The company focuses on developing evidence-based topical treatments for chronic skin conditions such as atopic dermatitis and sensitive skin syndrome. WEDERM leverages clinical research to formulate products that restore the skin barrier and modulate inflammatory responses without the use of harsh steroids. Their portfolio includes specialized cleansers, moisturizers, and therapeutic creams designed for both pediatric and adult populations.

Therapeutic areas: Dermatology
Modalities: Small moleculeTopical formulation
Industry: Biotech

Beyond the preview

Go deeper on WEDERM Global.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on WEDERM Global.

Explore the full profile